Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
05 04 2019
Historique:
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 14 2 2020
Statut: epublish

Résumé

Asia is home to the largest diabetic populations in the world. However, limited studies have quantified the association of diabetes with all-cause and cause-specific mortality in Asian populations. To evaluate the association of diabetes with all-cause and cause-specific mortality in Asia and to investigate potential effect modifications of the diabetes-mortality associations by participants' age, sex, education level, body mass index, and smoking status. This pooled analysis incorporated individual participant data from 22 prospective cohort studies of the Asia Cohort Consortium conducted between 1963 and 2006. A total of 1 002 551 Asian individuals (from mainland China, Japan, South Korea, Singapore, Taiwan, India, and Bangladesh) were followed up for more than 3 years. Cohort-specific hazard ratios and 95% confidence intervals for all-cause and cause-specific mortality were estimated using Cox regression models and then pooled using random-effects meta-analysis. Analysis was conducted between January 10, 2018, and August 31, 2018. Doctor-diagnosed diabetes, age, sex, education level, body mass index, and smoking status. All-cause and cause-specific mortality. Of 1 002 551 participants (518 537 [51.7%] female; median [range] age, 54.0 [30.0-98.0] years), 148 868 deaths were ascertained during a median (range) follow-up of 12.6 (3.0-38.9) years. The overall prevalence of diabetes reported at baseline was 4.8% for men and 3.6% for women. Patients with diabetes had a 1.89-fold risk of all-cause death compared with patients without diabetes (hazard ratio [HR], 1.89; 95% CI, 1.74-2.04), with the highest relative risk of death due to diabetes itself (HR, 22.8; 95% CI, 18.5-28.1), followed by renal disease (HR, 3.08; 95% CI, 2.50-3.78), coronary heart disease (HR, 2.57; 95% CI, 2.19-3.02), and ischemic stroke (HR, 2.15; 95% CI, 1.85-2.51). The adverse diabetes-mortality associations were more evident among women (HR, 2.09; 95% CI, 1.89-2.32) than among men (HR, 1.74; 95% CI, 1.62-1.88) (P for interaction < .001) and more evident among adults aged 30 to 49 years (HR, 2.43; 95% CI, 2.08-2.84) than among adults aged 70 years and older (HR, 1.51; 95% CI, 1.40-1.62) (P for interaction < .001). A similar pattern of association was found between diabetes and cause-specific mortality, with significant variations noted by sex and age. This study found that diabetes was associated with increased risk of death from several diseases among Asian populations. Development and implementation of diabetes management programs are urgently needed to reduce the burden of diabetes in Asia.

Identifiants

pubmed: 31002328
pii: 2730789
doi: 10.1001/jamanetworkopen.2019.2696
pmc: PMC6481439
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e192696

Subventions

Organisme : NCI NIH HHS
ID : R01 CA055069
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182876
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072507
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA043092
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA082729
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA173640
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA070867
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA080205
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA053890
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182910
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA144034
Pays : United States

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Am J Epidemiol. 2004 Jun 15;159(12):1160-7
pubmed: 15191933
JAMA. 2017 Jan 17;317(3):280-289
pubmed: 28114552
Diabetes Care. 2011 Jun;34(6):1249-57
pubmed: 21617109
Lancet. 2006 Nov 11;368(9548):1681-8
pubmed: 17098087
Diabet Med. 2006 Aug;23(8):857-66
pubmed: 16911623
Nutr Metab Cardiovasc Dis. 2009 Mar;19(3):190-7
pubmed: 18774701
Lancet. 2010 Jan 30;375(9712):408-18
pubmed: 19875164
Lancet. 2014 Jun 7;383(9933):1973-80
pubmed: 24613026
Diabet Med. 2018 Oct;35(10):1345-1354
pubmed: 29851428
Exp Mol Med. 2016 Mar 11;48:e219
pubmed: 26964835
Diabetologia. 2014 Aug;57(8):1542-51
pubmed: 24859435
N Engl J Med. 2016 Nov 17;375(20):1961-1971
pubmed: 27959614
Int J Diabetol Vasc Dis Res. 2015;2015(Suppl 1):
pubmed: 27583258
N Engl J Med. 2011 Mar 03;364(9):829-841
pubmed: 21366474
N Engl J Med. 2015 Oct 29;373(18):1720-32
pubmed: 26510021
Am J Epidemiol. 2003 Sep 15;158(6):543-52
pubmed: 12965880
Diabetes Care. 2012 Sep;35(9):1835-44
pubmed: 22699290
Stat Med. 2017 Feb 28;36(5):772-789
pubmed: 27910122
Diabetes Care. 2016 Mar;39(3):472-85
pubmed: 26908931
N Engl J Med. 2011 Feb 24;364(8):719-29
pubmed: 21345101
JAMA. 2005 Jan 12;293(2):194-202
pubmed: 15644546
Lancet Diabetes Endocrinol. 2018 Jul;6(7):538-546
pubmed: 29752194
Diabetologia. 2017 Jun;60(6):1022-1032
pubmed: 28265721
Stat Med. 2017 Feb 28;36(5):855-875
pubmed: 27747915
Diabetes Res Clin Pract. 1999 Jan;43(1):67-74
pubmed: 10199590
Lancet. 2011 Oct 1;378(9798):1231-43
pubmed: 21872920
Diabet Med. 2005 Mar;22(3):323-31
pubmed: 15717882
Environ Health Perspect. 2010 Sep;118(9):1299-305
pubmed: 20813654
PLoS One. 2011;6(6):e19930
pubmed: 21731609
Curr Diab Rep. 2018 Apr 18;18(6):33
pubmed: 29671082
Ann Oncol. 2011 Mar;22(3):730-8
pubmed: 20705912
Diabetes Care. 2016 Nov;39(11):1987-1995
pubmed: 27493134
Diabetes Care. 2003 Nov;26(11):2999-3005
pubmed: 14578230
Diabetes Care. 2003 Feb;26(2):360-6
pubmed: 12547863

Auteurs

Jae Jeong Yang (JJ)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Danxia Yu (D)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Wanqing Wen (W)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Eiko Saito (E)

Division of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

Shafiur Rahman (S)

Department of Global Health Policy, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Xiao-Ou Shu (XO)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Yu Chen (Y)

Department of Population Health, New York University School of Medicine, New York.
Department of Environmental Medicine, New York University School of Medicine, New York.

Prakash C Gupta (PC)

Healis-Sekhsaria Institute for Public Health, Mahape, Navi Mumbai, India.

Dongfeng Gu (D)

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Shoichiro Tsugane (S)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Yong-Bing Xiang (YB)

State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

Yu-Tang Gao (YT)

State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

Jian-Min Yuan (JM)

Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.

Akiko Tamakoshi (A)

Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Fujiko Irie (F)

Department of Health and Welfare, Ibaraki Prefectural Office, Mito, Japan.

Atsuko Sadakane (A)

Radiation Effects Research Foundation, Hiroshima, Japan.

Yasutake Tomata (Y)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Seiki Kanemura (S)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Ichiro Tsuji (I)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Keitaro Matsuo (K)

Division of Molecular & Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Chisato Nagata (C)

Graduate School of Medicine, Gifu University, Gifu City, Japan.

Chien-Jen Chen (CJ)

Academia Sinica, Taipei City, Taiwan.

Woon-Puay Koh (WP)

Health Services and Systems Research, Duke-NUS Medical School Singapore, Singapore, Republic of Singapore.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Republic of Singapore.

Myung-Hee Shin (MH)

Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Sue K Park (SK)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.
Cancer Research Institute, Seoul National University, Seoul, South Korea.

Pei-Ei Wu (PE)

Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei city, Taiwan.

You-Lin Qiao (YL)

National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

Mangesh S Pednekar (MS)

Healis-Sekhsaria Institute for Public Health, Mahape, Navi Mumbai, India.

Jiang He (J)

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.

Norie Sawada (N)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Hong-Lan Li (HL)

State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

Jing Gao (J)

State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.

Hui Cai (H)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Renwei Wang (R)

Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.

Toshimi Sairenchi (T)

Department of Public Health, Dokkyo Medical University School of Medicine, Mibu, Japan.

Eric Grant (E)

Radiation Effects Research Foundation, Hiroshima, Japan.

Yumi Sugawara (Y)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Shu Zhang (S)

Tohoku University Graduate School of Medicine, Sendai, Japan.

Hidemi Ito (H)

Division of Molecular & Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Keiko Wada (K)

Graduate School of Medicine, Gifu University, Gifu City, Japan.

Chen-Yang Shen (CY)

Institute of Biomedical Sciences, Academia Sinica, Taipei City, Taiwan.
College of Public Health, China Medical University, Taichung, Taiwan.

Wen-Harn Pan (WH)

Institute of Biomedical Sciences, Academia Sinica, Taipei City, Taiwan.

Yoon-Ok Ahn (YO)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.

San-Lin You (SL)

School of Medicine & Big Data Research Center, Fu Jen Catholic University, Taipei City, Taiwan.

Jin-Hu Fan (JH)

National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

Keun-Young Yoo (KY)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Armed Forces Capital Hospital, Seongnam, South Korea.

Habibul Ashan (H)

Department of Health Studies, University of Chicago, Chicago, Illinois.
Department of Medicine, University of Chicago, Chicago, Illinois.
Department of Human Genetics, University of Chicago, Chicago, Illinois.
Cancer Research Center, University of Chicago, Chicago, Illinois.

Kee Seng Chia (KS)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Republic of Singapore.

Paolo Boffetta (P)

Icahn School of Medicine at Mount Sinai, New York, New York.

Manami Inoue (M)

Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Daehee Kang (D)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.
Cancer Research Institute, Seoul National University, Seoul, South Korea.

John D Potter (JD)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Centre for Public Health Research, Massey University, Wellington, New Zealand.
Department of Epidemiology, University of Washington, Seattle.

Wei Zheng (W)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH